ArticleNPJ science of food2025
Prunella vulgaris seed oil alleviates cancer related fatigue through hypothalamic inflammation and CRH regulation.
Article in NPJ science of food, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From traditional warming and tonifying to psychoneuroimmunology: theoretical reconstruction and clinical application of moxibustion for cancer-related fatigue.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Cancer-related fatigue (CRF) is a common symptom in cancer patients, affecting their quality of life. Prunella vulgaris and its seed oil (PVSO) are edible-medicinal foods with bioactive compounds that may alleviate CRF. The present study aimed to test the effects of PVSO on CRF and underlying mechanisms. We found PVSO improved fatigue-like behaviors in both LPS-induced and tumor-bearing models. In the breast cancer tumor-bearing animals, PVSO reduced tumor growth, and suppressed serum and hypothalamic inflammatory cytokines (TNF-α, IL-1β, and IL-6) and NF-κB signaling. Furthermore, the hypothalamic corticotropin-releasing hormone (CRH) expression and serum CRH/cortisol levels dampened in tumor-bearing animals were normalized by PVSO. Our results suggest that PVSO exhibits potent anti-CRF effects likely via attenuation of cancer-induced hypothalamic inflammation and subsequent normalization of the dysregulated HPA axis. PVSO may be developed as a functional food for breast cancer-related fatigue.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.